← Leaderboards
Deliang Guo
Ohio State University
$11,121,635
Attributed
$11,875,742
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,875,742 · 7
By mechanism
R01$11,456,367 · 6
R21$419,375 · 1
Top collaborators
- Arnab Chakravarti5 shared
Most similar at Ohio State University
Same institution · by research overlap
- Ioanna Papandreou$960,263
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingMalignant NeoplasmsCellsGlioblastomaTumor GrowthEnzymesAdultPrimary Brain NeoplasmsLipidsMolecularBiologyIn VitroIn VivoGrowthMetabolismPlayCancer CellInsightCholesterolUptakeSre-1 Binding ProteinSamplingLipid BiosynthesisTumor Tissue
Grant awards (31)
Novel lipid and glutamine metabolism-based combination therapies for glioblastoma$629,750
R01 · FY2025 · NS · contact PI
Determining the role of lipid droplets and their therapeutic potential in glioblastoma$544,245
R01 · FY2025 · NS · contact PI
Determining the role of lipid droplets and their therapeutic potential in glioblastoma$527,917
R01 · FY2024 · NS · contact PI
Delineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanisms$418,800
R01 · FY2024 · CA · contact PI
Identifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolism$348,707
R01 · FY2024 · NS · contact PI
Determining the role of lipid droplets and their therapeutic potential in glioblastoma$558,620
R01 · FY2023 · NS · contact PI
Delineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanisms$432,023
R01 · FY2023 · CA · contact PI
Identifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolism$359,493
R01 · FY2023 · NS · contact PI
Defining the molecular mechanisms regulating the hexosamine-N-glycosylation pathway in glioblastoma$294,894
R01 · FY2023 · CA · contact PI
Delineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanisms$432,023
R01 · FY2022 · CA · contact PI
Determining the role of lipid droplets in glioblastoma and their therapeutic potential$408,589
R01 · FY2022 · NS · contact PI
Identifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolism$359,493
R01 · FY2022 · NS · contact PI
Defining the molecular mechanisms regulating the hexosamine-N-glycosylation pathway in glioblastoma$292,895
R01 · FY2022 · CA · contact PI
Delineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanisms$440,840
R01 · FY2021 · CA · contact PI
Determining the role of lipid droplets in glioblastoma and their therapeutic potential$408,589
R01 · FY2021 · NS · contact PI
Identifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolism$359,493
R01 · FY2021 · NS · contact PI
Defining the molecular mechanisms regulating the hexosamine-N-glycosylation pathway in glioblastoma$301,456
R01 · FY2021 · CA · contact PI
Delineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanisms$454,840
R01 · FY2020 · CA · contact PI
Determining the role of lipid droplets in glioblastoma and their therapeutic potential$408,589
R01 · FY2020 · NS · contact PI
Identifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolism$359,493
R01 · FY2020 · NS · contact PI
Defining the molecular mechanisms regulating the hexosamine-N-glycosylation pathway in glioblastoma$306,970
R01 · FY2020 · CA · contact PI
Determining the role of lipid droplets in glioblastoma and their therapeutic potential$408,589
R01 · FY2019 · NS · contact PI
Defining the molecular mechanisms regulating the hexosamine-N-glycosylation pathway in glioblastoma$312,000
R01 · FY2019 · CA · contact PI
Determining the role of lipid droplets in glioblastoma and their therapeutic potential$407,145
R01 · FY2018 · NS · contact PI
Targeting the cholesterol metabolism to treat glioblastoma$336,875
R01 · FY2017 · NS · contact PI
Targeting the cholesterol metabolism to treat glioblastoma$336,875
R01 · FY2016 · NS · contact PI
Targeting the cholesterol metabolism to treat glioblastoma$336,875
R01 · FY2015 · NS · contact PI
Targeting the cholesterol metabolism to treat glioblastoma$333,505
R01 · FY2014 · NS · contact PI
Targeting the cholesterol metabolism to treat glioblastoma$336,784
R01 · FY2013 · NS · contact PI
Targeting SREBP-1 regulated fatty acid synthesis pathway to treat glioblastoma$228,750
R21 · FY2012 · NS · contact PI
Targeting SREBP-1 regulated fatty acid synthesis pathway to treat glioblastoma$190,625
R21 · FY2011 · NS · contact PI